LTI-01: Ph Ia/Ib started

Lung Therapeutics began an Australian and New Zealand Phase Ia/Ib trial of once-daily LTI-01 delivered through a standard of care (SOC) in-dwelling chest tube for 3 days in about 21 patients with a bu...